AR and prostate carcinoma: In the current study, we sought to characterize prostate organoids generated from African American subjects that were engineered to express combination of MYC, AR, shPTEN and shTP53. These genetically engineered organoids became transformed in vitro and formed prostate cancer in vivo, validating organoid cultures as a model to study prostate tumorigenesis.